Helicobacter Pylori Screening and Treatment in the At-risk South Florida Community- AIM 1

计划入组 500 人 · 首次发布于 2025 年 11 月 3 日

Helicobacter Pylori Screening and Treatment in the At-risk South Florida Community-AIM 2

计划入组 75 人 · 首次发布于 2025 年 11 月 3 日

The Florida ASCENT Study

计划入组 100 人 · 首次发布于 2025 年 6 月 27 日

AIM-1

AIM-104

AIM-102

C₁₆H₂₇N₃O₆

Sincerus Florida, LLC

United States

Florida Pharmaceutical Products, LLC

United States

AIM VACCINE

China

Vivos Therapeutics and South Palm Cardiovascular Associates Finalize Agreements to Launch South Florida Sleep & Airway Medicine Center

Travere Therapeutics Pauses Enrollment in Phase 3 Homocystinuria Trial Due to Manufacturing Issues

MAIA Biotechnology's THIO Shows Promise in Phase II Lung Cancer Trial; Institutional Investment Increases